Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study

Soft Tissue Sarcoma Clinical Trial

Official title:

Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00611078
• Other study ID #: 04-088
• Status: Completed
• Phase: N/A
• First received: January 25, 2008
• Last updated: January 19, 2011
• Start date: September 2004
• Est. completion date: January 2011

Study information

• Verified date: January 2011
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: January 2011
• Est. primary completion date: January 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 79 Years

Eligibility

Inclusion Criteria:

• Patients with Soft tissue sarcoma at MSKCC are eligible for this study if they meet the following criteria:

• Between 18 and 79 years of age

• were diagnosed within the previous 6 months with primary soft tissue sarcoma of one of the following histologic subtypes: liposarcoma, leiomyoscaroma, MFH, or synovial sarcoma

• are enrolled in protocol 02-060 ("Novel Biochemical and Molecularr Determinants for Soft Tissue Sarcoma"; PI, Dr. Samuel Singer)

• controls will be eligibile for this study if they meet the following criteria

• are b/w 18-79 years of age

• have no prior history of cancer (other than non melanoma skin cancer)

Exclusion Criteria:

• Individuals will be excluded if they

• are unable to sign informed consent for medical or other reasons

• do not speak english

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Sarcoma
• Soft Tissue Sarcoma

Locations

Country	Name	City	State
United States	Memorial Sloan-Kettering Cancer Center	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	enrollment of 60 participants		Conclusion of the study	No